Psychobiology meeting in Natal defends innovative therapy in the country’s public health system
In just a 16-day interval, two events on psychedelics in Brazil addressed the political difficulty of resuming the benefits of these substances as alternative psychotherapeutic treatments. After the 2nd Brazilian Congress on Psychedelics in Rio de Janeiro, it was the turn of the 16th Symposium on Psychobiology in Natal to raise the banner of “psychedelics in the SUS.”
The acronym “SUS” stands for Sistema Único de Saúde, the universal public health system maintained by the Brazilian government. It was established by the 1988 Constitution, inspired by Britain’s National Health Service (NHS).
The meeting attracted around 200 people to the main auditorium in the Federal University of Rio Grande do Norte (UFRN) for three days of lectures and debates on the theme “Psychedelics in Mental Health – Charting the future of innovative therapies.” Many warnings were heard about the risk of them falling back into the limbo to which they have been relegated for over 30 years, leaving out millions of patients who could, in principle, benefit from them.
Read full article
Symposium in Brazil Debates Psychedelics at a Political Crossroads
